Human Cell Transformation pp 81-90

Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 720)

Prostate Tumor Cell Plasticity: A Consequence of the Microenvironment

Chapter

Abstract

During each step of prostate cancer metastasis, cancer displays phenotypic plasticity that is associated with the expression of both epithelial and mesenchymal properties or an epithelial to mesenchymal transition. This phenotypic transition is typically in response to microenvironment signals and is the basis for basic cancer cell survival (e.g. motility and invasion versus proliferation). In this review we discuss the loss and gain of E-cadherin expression as a marker of tumor plasticity throughout the steps of metastasis, and particularly focus on dynamic tumor–stromal interaction that induce a cancer cell-associated mesenchymal to epithelial reverting transition in the bone and liver microenvironments.

References

  1. 1.
    Kahn LB, Uys CJ, Dale J, Rutherfoord S (1978) Carcinoma of the breast with metaplasia to chondrosarcoma: a light and electron microscopic study. Histopathology 2:93–106PubMedCrossRefGoogle Scholar
  2. 2.
    Hay ED, Zuk A (1995) Transformations between ­epithelium and mesenchyme: normal, pathological, and experimentally induced. Am J Kidney Dis 26:678–690PubMedCrossRefGoogle Scholar
  3. 3.
    Ehrlich JS, Hansen MD, Nelson WJ (2002) Spatio-temporal regulation of Rac1 localization and lamellipodia dynamics during epithelial cell-cell adhesion. Dev Cell 3:259–270PubMedCrossRefGoogle Scholar
  4. 4.
    Akhtar N, Hudson KR, Hotchin NA (2000) Co-localization of Rac1 and E-cadherin in human epidermal keratinocytes. Cell Adhes Commun 7:465–476PubMedCrossRefGoogle Scholar
  5. 5.
    Ray ME, Mehra R, Sandler HM, Daignault S, Shah RB (2006) E-cadherin protein expression predicts prostate cancer salvage radiotherapy outcomes. J Urol 176:1409–1414, discussion 14PubMedCrossRefGoogle Scholar
  6. 6.
    Hennig G, Behrens J, Truss M, Frisch S, Reichmann E, Birchmeier W (1995) Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. Oncogene 11:475–484PubMedGoogle Scholar
  7. 7.
    Graff JR, Herman JG, Lapidus RG et al (1995) E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 55:5195–5199PubMedGoogle Scholar
  8. 8.
    Machado JC, Oliveira C, Carvalho R et al (2001) E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene 20:1525–1528PubMedCrossRefGoogle Scholar
  9. 9.
    Berx G, Becker KF, Hofler H, van Roy F (1998) Mutations of the human E-cadherin (CDH1) gene. Hum Mutat 12:226–237PubMedCrossRefGoogle Scholar
  10. 10.
    Hirohashi S (1998) Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 153:333–339PubMedCrossRefGoogle Scholar
  11. 11.
    Jennbacken K, Tesan T, Wang W, Gustavsson H, Damber JE, Welen K (2010) N-cadherin increases after androgen deprivation and is associated with metastasis in prostate cancer. Endocr Relat Cancer 17:469–479PubMedCrossRefGoogle Scholar
  12. 12.
    Tanaka H, Kono E, Tran CP et al (2010) Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance. Nat Med 16:1414–1420PubMedCrossRefGoogle Scholar
  13. 13.
    Tran NL, Nagle RB, Cress AE, Heimark RL (1999) N-cadherin expression in human prostate carcinoma cell lines. An epithelial-mesenchymal transformation mediating adhesion with stromal cells. Am J Pathol 155:787–798PubMedCrossRefGoogle Scholar
  14. 14.
    Odero-Marah VA, Wang R, Chu G et al (2008) Receptor activator of NF-kappaB ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells. Cell Res 18:858–870PubMedCrossRefGoogle Scholar
  15. 15.
    Liu J, Uygur B, Zhang Z et al (2010) Slug inhibits proliferation of human prostate cancer cells via downregulation of cyclin D1 expression. Prostate 70:1768–1777PubMedGoogle Scholar
  16. 16.
    Emadi Baygi M, Soheili ZS, Schmitz I, Sameie S, Schulz WA (2010) Snail regulates cell survival and inhibits cellular senescence in human metastatic prostate cancer cell lines. Cell Biol Toxicol 26:553–567PubMedCrossRefGoogle Scholar
  17. 17.
    Kwok WK, Ling MT, Lee TW et al (2005) Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res 65:5153–5162PubMedCrossRefGoogle Scholar
  18. 18.
    Yuen HF, Chan YP, Wong ML et al (2007) Upregulation of twist in oesophageal squamous cell carcinoma is associated with neoplastic transformation and distant metastasis. J Clin Pathol 60:510–514PubMedCrossRefGoogle Scholar
  19. 19.
    Downing JR, Reynolds AB (1991) PDGF, CSF-1, and EGF induce tyrosine phosphorylation of p120, a pp 60src transformation-associated substrate. Oncogene 6:607–613PubMedGoogle Scholar
  20. 20.
    Hazan RB, Norton L (1998) The epidermal growth factor receptor modulates the interaction of E-cadherin with the actin cytoskeleton. J Biol Chem 273:9078–9084PubMedCrossRefGoogle Scholar
  21. 21.
    Andl CD, Mizushima T, Nakagawa H et al (2003) Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal keratinocytes in vitro and in vivo. J Biol Chem 278:1824–1830PubMedCrossRefGoogle Scholar
  22. 22.
    Kassis J, Moellinger J, Lo H, Greenberg NM, Kim HG, Wells A (1999) A role for phospholipase C-gamma-mediated signaling in tumor cell invasion. Clin Cancer Res 5:2251–2260PubMedGoogle Scholar
  23. 23.
    Nakashiro K, Okamoto M, Hayashi Y, Oyasu R (2000) Hepatocyte growth factor secreted by prostate-derived stromal cells stimulates growth of androgen-­independent human prostatic carcinoma cells. Am J Pathol 157:795–803PubMedCrossRefGoogle Scholar
  24. 24.
    Yates C, Wells A, Turner T (2005) Luteinising ­hormone-releasing hormone analogue reverses the cell adhesion profile of EGFR overexpressing DU-145 human prostate carcinoma subline. Br J Cancer 92:366–375PubMedGoogle Scholar
  25. 25.
    Davies G, Jiang WG, Mason MD (2001) HGF/SF modifies the interaction between its receptor c-Met, and the E-cadherin/catenin complex in prostate cancer cells. Int J Mol Med 7:385–388PubMedGoogle Scholar
  26. 26.
    Josson S, Anderson CS, Sung SY et al (2011) Inhibition of ADAM9 expression induces epithelial phenotypic alterations and sensitizes human prostate cancer cells to radiation and chemotherapy. Prostate 71(3):232–240PubMedCrossRefGoogle Scholar
  27. 27.
    Graham TR, Zhau HE, Odero-Marah VA et al (2008) Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Res 68:2479–2488PubMedCrossRefGoogle Scholar
  28. 28.
    Yates C, Shepard CR, Papworth G et al (2007) Novel three-dimensional organotypic liver bioreactor to directly visualize early events in metastatic progression. Adv Cancer Res 97:225–246PubMedCrossRefGoogle Scholar
  29. 29.
    Yates CC, Shepard CR, Stolz DB, Wells A (2007) Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin. Br J Cancer 96:1246–1252PubMedCrossRefGoogle Scholar
  30. 30.
    Li LC, Zhao H, Nakajima K et al (2001) Methylation of the E-cadherin gene promoter correlates with progression of prostate cancer. J Urol 166:705–709PubMedCrossRefGoogle Scholar
  31. 31.
    Ma L, Teruya-Feldstein J, Weinberg RA (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449:682–688PubMedCrossRefGoogle Scholar
  32. 32.
    Lehmann U, Hasemeier B, Christgen M et al (2008) Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J Pathol 214:17–24PubMedCrossRefGoogle Scholar
  33. 33.
    Dalmay T, Edwards DR (2006) MicroRNAs and the hallmarks of cancer. Oncogene 25:6170–6175PubMedCrossRefGoogle Scholar
  34. 34.
    Kong D, Li Y, Wang Z et al (2009) miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells 27:1712–1721PubMedCrossRefGoogle Scholar
  35. 35.
    Wu TT, Sikes RA, Cui Q et al (1998) Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines. Int J Cancer 77:887–894PubMedCrossRefGoogle Scholar
  36. 36.
    Zhau HE, Li CL, Chung LW (2000) Establishment of human prostate carcinoma skeletal metastasis models. Cancer 88:2995–3001PubMedCrossRefGoogle Scholar
  37. 37.
    Paget S (1889) The distribution of secondary growths in cancer of the breast. Cancer Metastasis Rev 8:98–101Google Scholar
  38. 38.
    Chung LW (2003) Prostate carcinoma bone-stroma interaction and its biologic and therapeutic implications. Cancer 97:772–778PubMedCrossRefGoogle Scholar
  39. 39.
    Stessels F, Van den Eynden G, Van der Auwera I et al (2004) Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia. Br J Cancer 90:1429–1436PubMedCrossRefGoogle Scholar
  40. 40.
    Buijs JT, Rentsch CA, van der Horst G et al (2007) BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo. Am J Pathol 171:1047–1057PubMedCrossRefGoogle Scholar
  41. 41.
    Morrissey C, True LD, Roudier MP et al (2008) Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases. Clin Exp Metastasis 25:377–388PubMedCrossRefGoogle Scholar
  42. 42.
    Josson S, Sharp S, Sung SY (2010) et al. Tumor-stromal interactions influence radiation sensitivity in epithelial – versus mesenchymal-like prostate cancer cells, J OncolGoogle Scholar
  43. 43.
    Saha B, Kaur P, Tsao-Wei D et al (2008) Unmethylated E-cadherin gene expression is significantly associated with metastatic human prostate cancer cells in bone. Prostate 68:1681–1688PubMedCrossRefGoogle Scholar
  44. 44.
    Green SK, Karlsson MC, Ravetch JV, Kerbel RS (2002) Disruption of cell-cell adhesion enhances antibody-dependent cellular cytotoxicity: implications for antibody-based therapeutics of cancer. Cancer Res 62:6891–6900PubMedGoogle Scholar
  45. 45.
    Lamb LE, Knudsen BS, Miranti CK (2010) E-cadherin-mediated survival of androgen-receptor-expressing secretory prostate epithelial cells derived from a stratified in vitro differentiation model. J Cell Sci 123:266–276PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Department of Biology and Center for Cancer ResearchTuskegee UniversityTuskegeeUSA

Personalised recommendations